The insoluble excretion of multi-matrix system mesalazine preparations in patients with ulcerative colitis

BACKGROUND: Multi-matrix mesalazine (MMX) is an important treatment for ulcerative colitis (UC); however, it is often excreted intact, which increases the risk of relapse. This study aimed to clarify the risk factors for insoluble MMX excretion. METHODS: The subjects were 102 UC patients who were ne...

Descripción completa

Detalles Bibliográficos
Autores principales: Yuichiro, Ohtaki, Kan, Uchiyama, Hirotaka, Kamiya, Eri, Moriizumi, Moe, Yamada, Yuma, Aoki, Toshimune, Watanabe, Sachie, Kiryu, Sizuka, Suzuki, Yoshihiro, Matsumoto, Zensho, Ito, Toshifumi, Ohkusa, Shigeo, Koido, Masayuki, Saruta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9389853/
https://www.ncbi.nlm.nih.gov/pubmed/35982420
http://dx.doi.org/10.1186/s12876-022-02474-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9389853/
https://www.ncbi.nlm.nih.gov/pubmed/35982420
http://dx.doi.org/10.1186/s12876-022-02474-9

Ejemplares similares